A study released today in Stem Cells Translational Medicine suggests a new way to correct facial atrophy of localized scleroderma (LoS) in patients. It shows how applying grafts made up of the patient’s own fat enhanced with adipose-derived stem cells (ADSCs) is a safe, feasible and attractive alternative to conventional fat grafting or fat grafting combined with stromal vascular fraction in treating this condition.